Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VIVOLTA logo — Guiding the body to heal itself

VIVOLTA

Guiding the body to heal itself

Founded 2008 The Netherlands The Netherlands 38 employees Grant Total: $10.00M Health Care, Manufacturing +1

General Information

Company Name VIVOLTA
Founded Year 2008
Location The Netherlands The Netherlands
Employees 38
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with VIVOLTA. To contact VIVOLTA, visit vivolta.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 23, 2026

VIVOLTA is participating as an exhibitor at Medical Technology Ireland in Galway, inviting visitors to Booth 336.

Get alerts when VIVOLTA shows new signals

About VIVOLTA

VIVOLTA, with the slogan "Guiding the body to heal itself," is a prominent player in the healthcare industry. Established in 2008, the Netherlands-based company has earned a reputation as a trusted partner for the contract development and manufacturing of electrospun medical products. Their focus lies in guiding the body's natural healing processes through innovative solutions. Leveraging their expertise as a high-performance electrospinning equipment designer, VIVOLTA has transitioned into a leading Contract Development and Manufacturing Organization (CDMO) for electrospun medical devices and drug delivery systems. By catering to the healthcare and manufacturing industries, VIVOLTA has positioned itself at the intersection of cutting-edge technology and healthcare, addressing critical needs in medical advancements. Their most recent milestone was marked by a grant investment from Eurostars on 26 October 2023, pointing to the confidence investors have in the company's vision and capabilities. In a field driven by innovation and impactful solutions, VIVOLTA's commitment to advancing electrospun medical products underscores its potential for continued growth and influence within the healthcare landscape.

Taxonomy: healthcare industry, contract development, electrospun medical products, drug delivery systems, CDMO, electrospinning equipment, high-performance, healing, biomedical technology, innovation, precision medicine

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Eurostars
26 Oct 2023
Series A €7.00M 5
TIIN Capital Borski Fund Lumana Invest
TIIN Capital, Borski Fund +3
13 Jun 2023
Venture Round €3.00M 4
TIIN Capital Borski Fund Lumana Invest
TIIN Capital, Borski Fund +2
03 Sep 2020
Venture Round Undisclosed -
02 Mar 2012

VIVOLTA Alternatives & Competitors

View All Alternatives
VIVOLTA vs
Inoviv
Inoviv United Kingdom

Accelerating the Development of New Medicines with Targeted Proteomics

Venture round
34 employees
Biopharma, Biotechnology
VIVOLTA vs
Magle Chemoswed
Magle Chemoswed Sweden

We bring innovations from idea to product.

72 employees
Health Care, Manufacturing
VIVOLTA vs
Mineed Technology Co., Ltd.
Mineed Technology Co., Ltd. Thailand

Detachable Microneedle Platform for transdermal and intradermal drug delivery

Seed
14 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About VIVOLTA

Guiding the body to heal itself
VIVOLTA was founded in 2008.
VIVOLTA is headquartered in The Netherlands.
VIVOLTA operates in Health Care, Manufacturing and Medical Devices. Its work centres on healthcare industry, contract development, electrospun medical products and drug delivery systems.
VIVOLTA has approximately 38 employees.
VIVOLTA has completed 4 funding rounds, raising a total of $10.00M. The latest funding stage is Grant.
Top alternatives and competitors to VIVOLTA include Inoviv, Magle Chemoswed, Mineed Technology Co., Ltd., Fidelio Healthcare Limburg GmbH, JSK Biomed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VIVOLTA and Inoviv are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VIVOLTA, https://bouncewatch.com/company/vivolta, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes